[1]
F. P. Mansani, L. R. C. Ribas, G. W. Barbosa, E. Machinski, and M. O. Matera, “Clinical characteristics related to long-term survival in durable responders with human epidermal growth factor receptor-type 2 metastatic breast cancer: a systematic review”, MAST, vol. 35, no. suppl.1, Feb. 2026.